Skip to main content

Deep Vein Thrombosis News (Page 2)

FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots

November 2, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis - Recurrent Event, Deep Vein Thrombosis - First Event

Related drug support groups

Xarelto, Eliquis, Lovenox, apixaban, Pradaxa, rivaroxaban